Sodium Fructose Diphosphate Capsules

This product is a cell metabolite existing in the human body, which can regulate the activity of multiple enzyme systems in glucose metabolism. It is reported that exogenous sodium fructose diphosphate can increase the concentration of adenosine triphosphate and creatine phosphate in cells by activating the activity of phosphofructokinase and pyruvate kinase, promote the influx of potassium ions, and is beneficial to the energy metabolism and glucose utilization of cells under ischemic and hypoxic conditions, thereby reducing damage to ischemic myocardium.

The main ingredient of this product is sodium fructose diphosphate.

This product is a hard capsule, the contents of which are white or off-white fine particles with a slightly salty taste.

Auxiliary treatment for myocardial ischemia, angina pectoris and cerebral infarction.

Oral, 4 capsules each time, 4 times a day, or as directed by your doctor.

The main manifestations are mild symptoms of the digestive system, such as abdominal distension, nausea, upper abdominal burning sensation, loose stools, etc. Patients can generally tolerate it and there is no need to stop the medication.

It is contraindicated for patients who are allergic to this product, have hyperphosphatemia, or have renal failure.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

This product should be used alone and should not be dissolved in other drugs, especially in alkaline solutions and calcium salts.

Store at room temperature in a sealed and dry place.

0.325g (anhydrous)

18 months

Hainan Quanxing Pharmaceutical Co., Ltd.

• Founded in:

  2001-10-29

• Address:

  A06-2, Bonded Area, Haikou City, Hainan Province

• Tax NO.:

  91460000730066028H

• Registered Funds:

  54.29 million yuan

• Website:

  Log in to view

• Email:

  Log in to view